Ditemukan 7 dokumen yang sesuai dengan query :: Simpan CSV
ABSTRAK Telah dilakukan penelitian tentang hasil pengobatan dan variasi biaya TBMDR/ XDR di RSUP Persahabatan Jakarta dengan menggunakan strategi Programatic Management Drug Resistance Tuberculosis (PMDT), yang memerlukan jangka waktu pengobatan yang lama 18-24 bulan serta memerlukan biaya yang sangat tinggi. Tujuan umum adalah mengetahui hasil pengobatan dan variabel-variabel biaya TB-MDR/XDR. Penelitian ini adalalah penelitian operasional dengan metode campuran kuantitatif dan kualitatif. Sampel adalah semua pasien TB-MDR/XDR yang mulai diobati Agustus 2009 sampai 31 Desember 2010, berjumlah 104 pasien. Hasil pada penelitian ini lama pengobatan TB-XDR lebih panjang dan angka keberhasilan (lengkap dan sembuh) lebih rendah yaitu 42,9 % dan 80,9% jika dibandingakan dengan TB-MDR, tetapi angka keberhasilan ini jauh lebih tinggi dari angka keberhasilan di dunia. Biaya pasien sampai sembuh dan lengkap pada pasien TB-XDR Rp 91.704.767,33 lebih tinggi dari TB-MDR Rp 72.260.081,73. Biaya pasien TB-XDR yang meninggal Rp 63.246.069,- lebih tinggi dari TB-MDR Rp 34.142.692,44. Hal ini juga terjadi pada total biaya pengobatan TB-XDR dengan efek samping ringan lebih tinggi biayanya dari pada pasien TB-MDR. Penambahan lama pengobatan mempunyai peluang peningkatan biaya sebesar Rp 115.205,- per hari Jenis kelamin laki-laki yang bertempat tinggal di Jakarta Timur dengan lama pengobatan kurang dari 569 hari memiliki peluang 1.7 kali lebih tinggi mengalami kesembuhan dibandingkan dengan jenis kelamin perempuan, yang bertempat tinggal di daerah dan lama pengobatan yang sama. Kesimpulan : Angka keberhasilan pada TB-MDR dan TB-XDR pada penelitian ini lebih tinggi dari angka keberhasilan di dunia . Biaya total pengobatan TBXDR jauh lebih tinggi dari TB-XDR dan terdapat keeratan hubungan antara variabel biaya pengobatan dengan lama pengobatan.
ABSTRACT This research captured the Programmatic Management of Drug resistant Tuberculosis (PMDT) at Persahabatan Hospital, Jakarta which required long treatment duration which is 18-24 months and especially the treatment outcome and variation cost. The study aimed to know regarding the treatment outcome as well as cost variaties of MDR/XDR-TB patients. This is a operational research using a mixture of quantitative and qualitative methods. The samples were all treated MDR/XDR-TB patients who started treatment from August 2009 until December 31, 2010. Total number of sample were 104 patients. The results of this study revealed that duration of treatment for XDR-TB patients is longer than MDR-TB patients with lower success rate which are 42,9% and 80,9% respectively and was statistically significant. However this result is relatively higher than reports from many countries in the world. The cost per patient for those who cured and completed treatment was US$ 9,357 and US$ 7,373 for the XDR-TB patients and MDR-TB patients respectively which was statistically significant. The cost spent for XDR-TB patients who died during treatment was higher compare to MDR-TB ones, US$ 6,453 and US$ 3,484 respectively. The same finding was similar higher when comparing the total cost of mild side effect for XDR-TB and MDR-TB. Additional time for length of treatment would give the probability of spending US$ 11,75 per day. Male patients who live in East Jakarta with length of treatment was less than 569 days have the chance to cured 1.7 fold compare to females patient with the same condition in term of length of stay and residencial. Conclusion: Success Rate of MDR/XDR-TB in this study is higher than those being reported worldwide. Cost for XDR-TB is extremely high than for MDR-TB. There is an association found between cost and length of treatment.
Background: TB is listed as one of the deadliest diseases. The number of multidrug-resistant tuberculosis (MDR-TB) in the world is also still quite high. The incidence of drug withdrawal in MDR-TB is higher than the incidence of drug withdrawal in drug sensitive TB. Psychopathology and behavior is one of the main barriers to adherence to treatment. Mindfulness therapy method is part of cognitive - behavioral therapy that uses a psychological prevention approach. Mindfulness therapy method is expected to reduce the rate of drug withdrawal in patients receiving MDR-TB treatment regimens. This study aims to determine the clinical efficacy of mindfulness therapy method in reducing the incidence of drug withdrawal in patients receiving TB MDR therapy regimens along with an analysis of the costs involved. Method: This study is an experimental study with a single blind randomized controlled trial research design. The subjects of the study were patients with pulmonary TB who received the first month MDR-TB therapy regimen and went to the MDR polyclinic at Drajat Prawiranegara Serang General Hospital and South Tangerang General Hospital, Banten. Patients who met the inclusion and exclusion criteria were grouped into two groups namely group A (the mindfulness therapy group) and group B (the usual consultation group as a control) by random permuted blocks random allocation. The basic characteristics of the study subjects, the level of depression, anxiety level, and quality of life in each patient were measured at the beginning of the study. Depression level, anxiety level, and quality of life in each patient were remeasured every month until the total of each patient was obtained 5 times the measurement data. Interventions in the form of mindfulness therapy method and regular consultation will be given once a month in groups so that each patient will get intervention 4 times. The data obtained were analyzed by bivariate t-test analysis and chi square will then proceed with multivariate analysis of multivariate logistic regression. Number needed to treat (NNT) is calculated, and economic analysis will be performed by calculating the incremental cost effectiveness ratio (ICER). xi Universitas Indonesia Results: The study subjects in this study were 106 patients with pulmonary TB who received MDR-TB therapy regimen consisting of 65 male patients and 41 female patients. In the bivariate analysis it was found that the variables that had a relationship with the incidence of drug withdrawal were age (p = 0.034), therapeutic status (p = 0.001) and attendance in the sessions (p = 0.001). Mindfulness therapy method did not affect the incidence of drug withdrawal statistically(p = 0.440) but affected clinically. In multivariate analysis, it was found that only meeting attendance variables were associated with drug withdrawal events with p = 0.016 and relative risk (RR) 0.1. In addition, it was also found that the level of depression symptoms and depression index scores between groups A and group B after the completion of the intensive phase of therapy were significantly different with p = 0.012 and p = 0.015. Anxiety index score between group A and group B after the completion of intensive phase therapy also showed a significantly different value of p = 0.040. Calculation of Number Needed to Treat (NNT) shows that it is necessary to do mindfulness therapy method to 20 patients with pulmonary TB who receive intensive phase MDR TB therapy regimen in order to be able to prevent drug withdrawal in 1 patient. Total ideal cost needed for implementing 4 times mindfullness therapy to 50 patients is Rp 72.421.667,- and ideal unit cost per not withdrawal case in mindfulness therapy method group is Rp 1.508.785. ICER for decreasing number of patients with severe depression symptoms by doing mindfulness therapy method when compared to usual consultation is Rp. 299,625, Conclusion: Mindfulness therapy method has not been able to significantly reduce the rate of drug withdrawal statistically but able to reduce clinically in patients with pulmonary TB who are on the intensive phase of Multi Drug Resistant Tuberculosis (MDR TB) regimen. However, mindfulness therapy method in this study can significantly reduce depression symptoms and anxiety scores. Ideal unit cost per not withdrawal case in mindfulness therapy method group is Rp 1.508.785. Keywords Mindfulness therapy method, drug withdrawal, Multi Drug Resistant Tuberculosis, depression, anxiety, economic analysis.
